profit from every £100 of sales.
£0£100
Advanced Medical Solutions Group
£2.83+0.00% today
+26.1% in 1 year
1-year low £1.911-year high £2.83
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay £61.96 for every £1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Advanced Medical Solutions Group sold, what it kept, and what it did with the cash.
Sales went from £124 million in 2022 to £229 million in 2025, with £9.95 million of profit last year.
SalesProfit
Advanced Medical Solutions Group handed back 29% of the cash it generated last year.
£6M
Free cash flow 2025£20M
Bought back its own shares–
Paid as dividends£6M
Cash vs. debt£18M vs. £82M
Advanced Medical Solutions Group vs. similar companies
Advanced Medical Solutions Group grows the fastest of these 5 and is the most expensive for its profits.
| Company | Profit from £100 of sales | Sales growth a year | Price per £1 of profit |
|---|---|---|---|
| Advanced Medical Solutions Group | 62.0× · Very expensive | ||
 Intuitive Surgical | 55.9× · Expensive | ||
 EssilorLuxottica Société anonyme | 37.7× · Expensive | ||
 Becton, Dickinson and | 34.9× · Expensive | ||
 Medline | 46.2× · Expensive |
AI analysis
An AI analyst reads Advanced Medical Solutions Group's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of GBP | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 124 | 126 | 178 | 229 | |
| 73 | 70 | 93 | 122 | |
| 25 | 19 | 22 | 28 | |
| 35 | 32 | 30 | 44 | |
| 20 | 16 | 7 | 10 | |
| 0.09 | 0.07 | 0.03 | 0.05 | |
| 59.0% | 55.6% | 52.2% | 53.4% | |
| 20.0% | 15.0% | 12.5% | 12.4% | |
| 16.4% | 12.6% | 4.0% | 4.3% |
Balance sheet
| In millions of GBP | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 281 | 289 | 388 | 395 |
| Cash | 82 | 60 | 17 | 18 |
| Total debt | 10 | 9 | 87 | 82 |
| Total liabilities | 44 | 45 | 147 | 135 |
| 237 | 244 | 241 | 259 | |
| 219 | 219 | 218 | 220 | |
| 8.0% | 6.4% | 3.0% | 5.0% | |
| 8.6% | 6.5% | 2.9% | 3.8% |
Cash flow
| In millions of GBP | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 27 | 12 | 19 | 33 | |
| 10 | 10 | 9 | 13 | |
| 17 | 2 | 11 | 20 | |
| Dividends paid | 4 | 5 | 5 | 6 |
| 0 | 7 | 0 | – | |
| 2 | 3 | 3 | 4 |
Valuation
- 62.0×
- –
- –
- 1.9×
- 2.7×
- 30.9×
- 15.5×
- 3.2%
- 1.6%
- 0.9%
Profitability
- 53.4%
- 12.4%
- 4.3%
- –
- 5.0%
- 5.6%
- –
- –
- –
- –
Growth
- +22.6%
- −21.4%
- –
- –
- +0.1%
Financial health
- 1.4×
- 0.32
- –
- 4.7×
- 2.79
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 50%of 948
Top 42%of 871
Bottom 16%of 560
Top 25%of 868
Top 32%of 985
0.9%of the share price, paid each year
On $1,000 invested$9a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
58.2% of its profit
Room to growStretchedMore than it earns: 29.0%
News
Nvidia’s China Spy Fallout Deepens: Report Says Moonshot AI Accessed NVDA’s Advanced Chips Despite Export ControlsYahoo Finance · Nov 10, 2026Nvidia Is Reportedly Pouring Billions Into AI's Next Big Bottleneck: Advanced Chip PackagingYahoo Finance · Nov 6, 2026Nvidia’s Megaspeed ties show potential blind spots in the U.S. effort to block China from accessing advanced chipsMarketWatch · Oct 31, 2026Nvidia, Chipmakers Face Higher Costs? TSMC Reportedly Plans Up To 20% Price Hike For Advanced Chip PackagingYahoo Finance · Oct 27, 2026Ivanhoe Electric in advanced talks to sell copper from Arizona project, CEO saysSeeking Alpha · Oct 19, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
45No pass
Benjamin Graham
54No pass
Philip Fisher
39No pass
Peter Lynch
40No pass
Joel Greenblatt
2No pass
Charlie Munger
34No pass
Terry Smith
38No pass
Questions about Advanced Medical Solutions Group
Is Advanced Medical Solutions Group a good stock to buy?
A business with weak numbers, priced as if everything goes right. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Advanced Medical Solutions Group AI analysis
What does Advanced Medical Solutions Group do?
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe, the United States, and internationally. It is in Medical Instruments & Supplies, based in Winsford, United Kingdom, with 1,800 employees.
Does Advanced Medical Solutions Group pay a dividend?
Yes. At today's price the dividend is 0.9% a year, about 58% of its yearly profit. In 2025 it paid out £5.79 million in dividends.
Is Advanced Medical Solutions Group stock halal?
Yes. Advanced Medical Solutions Group passes our halal screen: its business is permitted and its debt is 13% of its market value, under the 30% limit. How we check
How has Advanced Medical Solutions Group stock done over the past year?
Up 26.1% over the past twelve months, to £2.83. It traded between £1.91 and £2.83, close to its high.
Who are Advanced Medical Solutions Group's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with Advanced Medical Solutions Group's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.